Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 8 | 2024 | 497 | 3.000 |
Why?
|
| Linaceae | 4 | 2020 | 4 | 2.630 |
Why?
|
| Antioxidants | 5 | 2021 | 1668 | 1.290 |
Why?
|
| Plant Leaves | 4 | 2020 | 150 | 1.070 |
Why?
|
| Neuroprotective Agents | 3 | 2021 | 957 | 0.910 |
Why?
|
| Fatty Acids, Volatile | 1 | 2024 | 103 | 0.870 |
Why?
|
| Drug Carriers | 1 | 2024 | 706 | 0.650 |
Why?
|
| Nanostructures | 1 | 2024 | 552 | 0.630 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 8601 | 0.610 |
Why?
|
| Silver | 1 | 2018 | 117 | 0.590 |
Why?
|
| Memory Disorders | 2 | 2020 | 1199 | 0.500 |
Why?
|
| Flavonoids | 1 | 2018 | 445 | 0.490 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 399 | 0.450 |
Why?
|
| Lipids | 1 | 2024 | 3341 | 0.410 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 2226 | 0.400 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 9542 | 0.390 |
Why?
|
| Oxidative Stress | 2 | 2020 | 3113 | 0.380 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 983 | 0.370 |
Why?
|
| Acetylcholinesterase | 3 | 2021 | 156 | 0.360 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 3839 | 0.360 |
Why?
|
| Cognition | 2 | 2023 | 6992 | 0.320 |
Why?
|
| Scopolamine | 2 | 2020 | 93 | 0.310 |
Why?
|
| Avoidance Learning | 2 | 2020 | 248 | 0.280 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 18255 | 0.280 |
Why?
|
| Maze Learning | 2 | 2020 | 483 | 0.280 |
Why?
|
| Cognition Disorders | 2 | 2017 | 3980 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 22173 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 7406 | 0.230 |
Why?
|
| Posterior Eye Segment | 1 | 2024 | 17 | 0.230 |
Why?
|
| Rats | 4 | 2024 | 23741 | 0.230 |
Why?
|
| Stilbenes | 1 | 2024 | 155 | 0.220 |
Why?
|
| Nanocapsules | 1 | 2024 | 94 | 0.220 |
Why?
|
| Picrates | 2 | 2021 | 13 | 0.210 |
Why?
|
| Ethanol | 2 | 2018 | 1324 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 1936 | 0.200 |
Why?
|
| Coumaric Acids | 1 | 2021 | 13 | 0.200 |
Why?
|
| Dioscorea | 2 | 2017 | 2 | 0.180 |
Why?
|
| Bacopa | 2 | 2017 | 2 | 0.180 |
Why?
|
| Hippophae | 2 | 2017 | 3 | 0.180 |
Why?
|
| Body Weight | 2 | 2024 | 4618 | 0.180 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2021 | 242 | 0.170 |
Why?
|
| Animals | 10 | 2024 | 168475 | 0.160 |
Why?
|
| Plant Stems | 1 | 2018 | 19 | 0.160 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 353 | 0.160 |
Why?
|
| Green Chemistry Technology | 1 | 2018 | 10 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2021 | 10766 | 0.150 |
Why?
|
| Eye Diseases | 1 | 2024 | 653 | 0.150 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 271 | 0.150 |
Why?
|
| Acetylcholine | 1 | 2020 | 629 | 0.150 |
Why?
|
| Superoxides | 1 | 2018 | 387 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2024 | 1119 | 0.150 |
Why?
|
| Biphenyl Compounds | 2 | 2021 | 1007 | 0.140 |
Why?
|
| Anti-Anxiety Agents | 1 | 2020 | 397 | 0.140 |
Why?
|
| Patents as Topic | 1 | 2017 | 111 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2020 | 960 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 13642 | 0.120 |
Why?
|
| Plants, Medicinal | 1 | 2015 | 165 | 0.120 |
Why?
|
| Soil | 1 | 2015 | 115 | 0.120 |
Why?
|
| Metals | 1 | 2018 | 719 | 0.120 |
Why?
|
| Plant Preparations | 1 | 2014 | 94 | 0.110 |
Why?
|
| Metals, Heavy | 1 | 2015 | 148 | 0.110 |
Why?
|
| Rats, Wistar | 1 | 2017 | 1848 | 0.110 |
Why?
|
| Cell Survival | 2 | 2024 | 5791 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 8181 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2018 | 2231 | 0.100 |
Why?
|
| Water | 1 | 2018 | 1411 | 0.100 |
Why?
|
| Biological Products | 1 | 2021 | 914 | 0.100 |
Why?
|
| Eating | 1 | 2018 | 1539 | 0.100 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 1277 | 0.090 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 1457 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2024 | 6391 | 0.080 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 1460 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2022 | 3964 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12794 | 0.080 |
Why?
|
| Mice | 3 | 2023 | 81539 | 0.070 |
Why?
|
| Memory | 1 | 2017 | 2193 | 0.070 |
Why?
|
| Drug Discovery | 1 | 2015 | 1051 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2018 | 4217 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 16990 | 0.070 |
Why?
|
| Male | 6 | 2024 | 360841 | 0.060 |
Why?
|
| Brain | 2 | 2023 | 27121 | 0.060 |
Why?
|
| Receptors, Adiponectin | 1 | 2022 | 81 | 0.050 |
Why?
|
| Butyrylcholinesterase | 1 | 2021 | 21 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2024 | 11122 | 0.050 |
Why?
|
| Horses | 1 | 2021 | 300 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 2264 | 0.040 |
Why?
|
| Particle Size | 1 | 2024 | 1648 | 0.040 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 598 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 760 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2021 | 1880 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2022 | 1111 | 0.030 |
Why?
|
| Adiponectin | 1 | 2022 | 1113 | 0.030 |
Why?
|
| Rhizome | 1 | 2015 | 8 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 3076 | 0.030 |
Why?
|
| Plant Components, Aerial | 1 | 2014 | 5 | 0.030 |
Why?
|
| Indans | 1 | 2014 | 92 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2014 | 157 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 656 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2021 | 5439 | 0.020 |
Why?
|
| Humans | 5 | 2024 | 761578 | 0.020 |
Why?
|
| Fruit | 1 | 2015 | 1160 | 0.020 |
Why?
|
| United States | 1 | 2017 | 72335 | 0.020 |
Why?
|
| India | 1 | 2015 | 2348 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2014 | 2048 | 0.020 |
Why?
|
| Insulin | 1 | 2022 | 6597 | 0.020 |
Why?
|
| Piperidines | 1 | 2014 | 1656 | 0.020 |
Why?
|
| Disease Management | 1 | 2014 | 2508 | 0.010 |
Why?
|
| Female | 2 | 2018 | 392688 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2014 | 12341 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39107 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 58983 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 169308 | 0.000 |
Why?
|
| Middle Aged | 1 | 2014 | 220917 | 0.000 |
Why?
|
Concepts
(113)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_